Fittingly for the Back to the Future theme, delegates and exhibitors took what appeared to be a jump back in time at August’s Cornea and Contact Lens Society (CCLS) conference in Auckland – back to when it was the norm for more than 100 like-minded individuals to congregate, be intellectually stimul
Diabetic retinopathy (DR) is one of the microvascular complications of diabetes mellitus. In most patients it is symmetrical between the two eyes. In 5-10% of patients, however, DR can be
This update will answer some of the common questions surrounding herpes zoster ophthalmicus (HZO) and highlight recent research, including several key findings from studies performed in Auckland.
Efficacy, durability, and safety of intravitreal faricimab with extended dosing in patients with DMO
Dry eye disease (DED) occurs more frequently in women than in men and it’s recognised that hormones play an important role in the health and preservation of ocular surface tissues. Studies have demonstrated a direct link between hormones and susceptibility to DED1-4, linked to the presence of sex-st
Computer use is ubiquitous in contemporary society. Up to 69% of computer users report eye strain1,2, sometimes referred to as ‘computer vision syndrome’ (CVS) or ‘digital eye strain’. Although a range of interventions have been investigated for this common condition, currently there are no clinical
Ocular graft-versus-host disease (oGvHD) manifests in 60-80% of patients undergoing allogeneic haematopoietic stem cell transplantation, due to donor T cells incorrectly identifying recipient tissue as foreign, leading to an immunological attack by the donor cells1.
It seems we are finally making it out of the Covid era. For the last couple of years, just as things seemed to pick up slightly, another wave hit. After so much disruption, it feels like now is the time to normalise the situation. Yet, after such a historical global event, returning to ‘normal’ feel
The Save Sight Dry Eye Registry (SSDR) is the first multinational, web-based interdisciplinary registry able to collect high-quality outcome data from dry eye patients in clinical settings. With over 35 clinicians at 30 sites in Australia, New Zealand, Spain, Germany and the UK, the registry has gro
Activation and elevation of inflammatory mediators is associated with the pathogenesis and progression of dry eye disease (DED)¹. The quantification of inflammatory marker levels can provide insight into the disease progression and severity and may help guide individualised treatment. However, a var
The misconception that dry eye disease (DED) primarily affects the elderly presents a risk of overlooking issues in children. DED has been reported in paediatric populations with a prevalence of up to 33%1. As in adults, risk factors for paediatric DED include diabetes, Sjögren’s syndrome, blepharok
The prevalence and severity of dry eye disease (DED) is known to increase with age1. However, several recent studies have reported a high prevalence in younger populations. Increased digital screen use, particularly during the Covid-19 pandemic, has been associated with symptomatic DED in 70.8% of u
